Malaria is a vector-borne infectious disease caused by protozoan parasites. It is widespread in tropical and subtropical regions annually killing 2.7 million people; 90% in Sub-Saharan Africa. Malaria outbreaks are being reported in some locations of Africa that had been previously thought to be at elevations too high for malaria transmission, such as the highlands of Kenya. Some scientists hypothesise that this is due to climatic change, while others believe this is due to human migration. Malaria has long been endemic to Kenya’s humid coast and swampy lowland regions, but it has only rarely reached villages on the slopes of Mount Kenya. Other possible factors are deforestation, changes in land and water use. High death rates have been attributed the lack of resistance in traditional “non-malaria” regions and the growing resistance of the disease to commonly-used drugs.
The majority of those infected will not be able to afford any treatment. Additionally, parasites have evolved to be resistant to many antimalarial drugs. Therefore, in some areas of the world, only a few drugs remain as effective treatments for malaria. World Health Organisation studies indicate that up to 40% of artesunate based malaria medications are counterfeit. TVF procured much sought after and current antimalarial dosage to give one hundred children a chance for relief.